OOIR: Observatory of International Research

Papers

(The TQCC of Immunology and Allergy Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Defining Common Variable Immunodeficiency Disorders in 2020	34
Allergic Rhinitis in Children and Adolescents	33
The Microbiome and Chronic Rhinosinusitis	29
Anaphylaxis and Mast Cell Disorders	27
Global Climate Change and Pollen Aeroallergens	27
The Role of Extreme Weather and Climate-Related Events on Asthma Outcomes	22
Biologics for the Treatment of Allergic Rhinitis, Chronic Rhinosinusitis, and Nasal Polyposis	21
Odontogenic Sinusitis	20
Racial/Ethnic Differences in Food Allergy	20
Olfactory Dysfunction and Chronic Rhinosinusitis	20
The Role of Macrolides and Doxycycline in Chronic Rhinosinusitis	19
Innate Immunity	19
Dietary Management of Food Allergy	19
Biologics for the Treatment of Allergic Conditions: Eosinophil Disorders	18
IKAROS Family Zinc Finger 1–Associated Diseases in Primary Immunodeficiency Patients	17
Chronic Lung Disease in Primary Antibody Deficiency	16
The Role of Biologics in the Treatment of Nasal Polyps	15
The Role of Allergic Rhinitis in Chronic Rhinosinusitis	15
Genetics of Food Allergy	14
Targeting Mast Cells with Biologics	14
Climate Change and Pollen Allergy in India and South Asia	14
Air Pollution Effects in Allergies and Asthma	13
Skin Testing Approaches for Immediate and Delayed Hypersensitivity Reactions	12
Biologics for Atopic Dermatitis	12
Personalized Medicine in Chronic Rhinosinusitis	11

Climate Change, Air Pollution, and Biodiversity in Asia Pacific and Impact on Respiratory Allergies	11
The Impact of Climate Change on Pollen Season and Allergic Sensitization to Pollens	11
Biologics and Novel Therapies for Food Allergy	11
What is the Role of Air Pollution in Chronic Rhinosinusitis?	11
The Infant Microbiome and Its Impact on Development of Food Allergy	10
Current Concepts in the Management of Allergic Fungal Rhinosinusitis	10
The Role of Smoking in Asthma and Chronic Obstructive Pulmonary Disease Overlap	10
Biologics for the Treatments of Allergic Conditions	9
The Who, What, Where, When, Why, and How of Drug Desensitization	9
Asplenia and Hyposplenism	9
Monoclonal Antibodies (Biologics) for Allergic Rhinitis, Asthma, and Atopic Dermatitis During Pregnancy and Lactation	9
Contact Urticaria	9
Precision Therapy for the Treatment of Primary Immunodysregulatory Diseases	8
New Insights and Treatments in Atopic Dermatitis	8
Hemophagocytic Lymphohistiocytosis	8
Anaphylaxis	8
Innate Immune Regulation of Dermatitis	8
Biologics and Allergy Immunotherapy in the Treatment of Allergic Diseases	8
Allergy to Radiocontrast Dye	8
Perioperative Anaphylaxis	8
Immune-Related Adverse Drug Reactions and Immunologically Mediated Drug Hypersensitivity	8
Mas-Related G Protein–Coupled Receptor-X2 and Its Role in Non-immunoglobulin E–Mediated Drug Hypersensitivity	7
Effect of Climate Change on Allergenic Airborne Pollen in Japan	7
Advances in the Pathomechanisms of Delayed Drug Hypersensitivity	7
Psychosocial Aspects of Food Allergy	7
Anaphylaxis	7
The Unmet Needs of Patients with Food Allergies	7
Pharmacogenomics of Drug Hypersensitivity	7
Phenotypes of Asthma–Chronic Obstructive Pulmonary Disease Overlap	7
Recognizing Drug Hypersensitivity in Pigmented Skin	6
Insect Migration and Changes in Venom Allergy due to Climate Change	6
Diagnosis and Management of Food Allergy	6
Allergenic Pollen Season Variations in the Past Two Decades Under Changing Climate in the United States	6
The Importance of Primary Immune Deficiency Registries	6
Vaccines in Patients with Primary Immune Deficiency	6
Management of Anaphylaxis	6
Pathophysiology of Immunologic and Nonimmunologic Systemic Reactions Including Anaphylaxis	6
Pediatric Allergic Contact Dermatitis	6
Systemic Allergic Reactions and Anaphylaxis Associated with Allergen Immunotherapy	6
Drug Hypersensitivity Reactions	5
Pediatric Drug Allergy	5
Biologics for the Treatment of Food Allergies	5
The Use of Electronic Health Records to Study Drug-Induced Hypersensitivity Reactions from 2000 to 2021	5
Viral Infections and Wheezing in Preschool Children	5
Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis	5
Climate Change and Extreme Weather Events in Australia	5
Anaphylaxis to Excipients in Current Clinical Practice	5
Management of Sinusitis in the Cystic Fibrosis Patient	5
Asthma-Chronic Obstructive Pulmonary Disease Overlap	5
Climate Change Factors and the Aerobiology Effect	5

Anaphylaxis in Children and Adolescents	5
Biologic Agents for the Treatment of Anaphylaxis	5
Hypersensitivity Reactions and Immune-Related Adverse Events to Immune Checkpoint Inhibitors: Approaches, Mechanisms, and Models	4
Sarcoidosis	4
Topical Irrigations for Chronic Rhinosinusitis	4
Recognition and Management of Food Allergy and Anaphylaxis in the School and Community Setting	4
Nasal Polyposis and Aspirin-Exacerbated Respiratory Disease	4
Ozone in the Development of Pediatric Asthma and Atopic Disease	4
Anaphylaxis	4
Newborn Screening for Severe Combined Immunodeficiency	4
Tackling Food Allergy in Infancy	4
Eosinophilic Lung Diseases	4
Current and Potential Biologic Drugs for the Treatment of Chronic Urticaria	4
A Risk-Based Approach to Penicillin Allergy	4
Mimics of Dermatitis	4
Primary Immunodeficiency and Rhinosinusitis	4
Forecast for Pollen Allergy	4